Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy

Keluoxin (KLX) is an active agent in the treatment of diabetic retinopathy (DR). However, its mechanism, targets, and effective constituents against DR are still unclear, which seriously restricts its clinical application. Chinmedomics has the promise of explaining the pharmacological effects of her...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Ling, Sun, Ye, Sun, Hui, Zhang, Ai-hua, Zhang, Bo, Ge, Nan, Wang, Xi-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008273/
https://www.ncbi.nlm.nih.gov/pubmed/35431942
http://dx.doi.org/10.3389/fphar.2022.728256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008273/
https://www.ncbi.nlm.nih.gov/pubmed/35431942
http://dx.doi.org/10.3389/fphar.2022.728256

Ejemplares similares